McMaster University and Sartorius Partner to Lower Medication Manufacturing Costs

Researchers at McMaster University have partnered with global life sciences company Sartorius to develop more efficient biomanufacturing processes, McMaster News reported. The project aims to lower the cost of manufacturing therapeutics and reduce expenses for patients. [1]

The research team is led by Chemical Engineering professors David Latulippe and Prashant Mhaskar, according to McMaster News. Working inside a 1,600-square-foot research facility located near the McMaster University Medical Centre, the team has collaborated with Sartorius since 2021 to improve hardware and software used in drug production. [1]

Sartorius is a supplier of laboratory technologies and life sciences research tools headquartered in Göttingen, Germany, McMaster News reported. The collaborative project focuses on optimizing hardware and software systems to streamline the production of critical medications. [1]

Efforts to lower drug production costs follow previous global progress in accessible medicine. As HEROIC BREAKING NEWS reported earlier, domestic manufacturing initiatives in Bangladesh previously reduced the cost of critical treatments, such as lowering the price of the lung cancer drug Erlonix from Tk7,500 to Tk750. [2]